Fig. 4From: Exploration of the radiosensitivity-related prognostic risk signature in patients with glioma: evidence from microarray dataRadiotherapy stratification analysis. The RRPRS could further divide patients with glioma with radiotherapy (a–c) or without radiotherapy (d–f) into two groups with significantly different PFS valuesBack to article page